123 related articles for article (PubMed ID: 3621221)
1. Phase II trial of etoposide in the management of advanced or recurrent squamous cell carcinoma of the vulva and carcinoma of the vagina: a Gynecologic Oncology Group Study.
Slayton RE; Blessing JA; Beecham J; DiSaia PJ
Cancer Treat Rep; 1987 Sep; 71(9):869-70. PubMed ID: 3621221
[No Abstract] [Full Text] [Related]
2. Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Slayton RE; Blessing JA; Homesley HD
Cancer Treat Rep; 1984 Dec; 68(12):1513-4. PubMed ID: 6509456
[No Abstract] [Full Text] [Related]
3. Chemotherapy of squamous cell carcinoma of the cervix, vagina, and vulva.
Malkasian GD; Decker DG; Mussey E; Johnson CE
Clin Obstet Gynecol; 1968 Jun; 11(2):367-81. PubMed ID: 4879371
[No Abstract] [Full Text] [Related]
4. Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
Slayton RE; Blessing JA; Delgado G
Cancer Treat Rep; 1982 Aug; 66(8):1669-71. PubMed ID: 7105059
[No Abstract] [Full Text] [Related]
5. Phase II trial of etoposide in the management of advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.
Slayton RE; Blessing JA; DiSaia PJ; Christopherson WA
Cancer Treat Rep; 1987 Jun; 71(6):661-2. PubMed ID: 3034423
[No Abstract] [Full Text] [Related]
6. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
[TBL] [Abstract][Full Text] [Related]
7. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
8. Bleomycin alone or combined with mitomycin C in treatment of advanced or recurrent squamous cell carcinoma of the vulva.
Tropé C; Johnsson JE; Larsson G; Simonsen E
Cancer Treat Rep; 1980; 64(4-5):639-42. PubMed ID: 6159078
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study.
Slayton RE; Creasman WT; Petty W; Bundy B; Blessing JA
Cancer Treat Rep; 1979; 63(11-12):2089-92. PubMed ID: 526942
[No Abstract] [Full Text] [Related]
10. Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience.
Slavik M; Arsenau JC; Blessing J; Lewis GC
Am J Clin Oncol; 1982 Oct; 5(5):483-6. PubMed ID: 6897490
[No Abstract] [Full Text] [Related]
11. Phase II clinical trial of diaziquone in the treatment of patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Slayton RE; Blessing JA; Stehman FB; Malfetano J
Cancer Treat Rep; 1986 Sep; 70(9):1127-8. PubMed ID: 3742494
[No Abstract] [Full Text] [Related]
12. [Chemotherapy of carcinoma of the vulva and vagina. Current approaches].
Sesti F; Ciancio F; Bancheri C; Iannarilli P; Silvestri C; Piccione E
G Ital Oncol; 1989; 9(4):117-20. PubMed ID: 2693347
[TBL] [Abstract][Full Text] [Related]
13. Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A gynecologic oncology group study.
Muss HB; Bundy BN; Christopherson WA
Am J Clin Oncol; 1989 Apr; 12(2):142-4. PubMed ID: 2705404
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva.
Omura GA; Shingleton HM; Creasman WT; Blessing JA; Boronow RC
Cancer Treat Rep; 1978 May; 62(5):833-5. PubMed ID: 350400
[No Abstract] [Full Text] [Related]
15. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
16. Adriamycin treatment of advanced vulvar carcinoma.
Deppe G; Bruckner HW; Cohen CJ
Obstet Gynecol; 1977 Jul; 50(1 Suppl):13s-14s. PubMed ID: 876532
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Bonomi P; Blessing JA; Sedlacek TV; Homesley HD; DiSaia PJ
Cancer Treat Rep; 1983 Feb; 67(2):197-8. PubMed ID: 6687445
[No Abstract] [Full Text] [Related]
18. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Rose PG; Blessing JA; Arseneau J
Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
[TBL] [Abstract][Full Text] [Related]
19. Healing of vulvo-vaginal radionecrosis following revascularization.
Hoffman KE; Horowitz NS; Russell AH
Gynecol Oncol; 2007 Jul; 106(1):262-4. PubMed ID: 17507081
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of amsacrine in metastatic or locally recurrent squamous cell carcinoma from head and neck primaries: a Southwest Oncology Group study.
Witherspoon RP; Legha SS; Reimer RR; Talley RW; Stuckey WJ; Dixon DO; McCracken JD; Stephens RL; Oishi N
Cancer Treat Rep; 1984 Feb; 68(2):435-6. PubMed ID: 6546532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
